Literature DB >> 25792152

Organizational Justice and Physiological Coronary Heart Disease Risk Factors in Japanese Employees: a Cross-Sectional Study.

Akiomi Inoue1, Norito Kawakami2, Hisashi Eguchi3, Koichi Miyaki4,5, Akizumi Tsutsumi6.   

Abstract

BACKGROUND: Growing evidence has shown that lack of organizational justice (i.e., procedural justice and interactional justice) is associated with coronary heart disease (CHD) while biological mechanisms underlying this association have not yet been fully clarified.
PURPOSE: The purpose of the present study was to investigate the cross-sectional association of organizational justice with physiological CHD risk factors (i.e., blood pressure, high-density lipoprotein [HDL] cholesterol, low-density lipoprotein [LDL] cholesterol, and triglyceride) in Japanese employees.
METHODS: Overall, 3598 male and 901 female employees from two manufacturing companies in Japan completed self-administered questionnaires measuring organizational justice, demographic characteristics, and lifestyle factors. They completed health checkup, which included blood pressure and serum lipid measurements. Multiple logistic regression analyses and trend tests were conducted.
RESULTS: Among male employees, multiple logistic regression analyses and trend tests showed significant associations of low procedural justice and low interactional justice with high triglyceride (defined as 150 mg/dL or greater) after adjusting for demographic characteristics and lifestyle factors. Among female employees, trend tests showed significant dose-response relationship between low interactional justice and high LDL cholesterol (defined as 140 mg/dL or greater) while multiple logistic regression analysis showed only marginally significant or insignificant odds ratio of high LDL cholesterol among the low interactional justice group. Neither procedural justice nor interactional justice was associated with blood pressure or HDL cholesterol.
CONCLUSION: Organizational justice may be an important psychosocial factor associated with increased triglyceride at least among Japanese male employees.

Entities:  

Keywords:  Cholesterol; Cross-sectional studies; Hypertension; Interactional justice; Procedural justice; Triglyceride

Mesh:

Substances:

Year:  2015        PMID: 25792152     DOI: 10.1007/s12529-015-9480-4

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  34 in total

1.  Organization justice evaluations, job control, and occupational strain.

Authors:  M Elovainio; M Kivimäki; K Helkama
Journal:  J Appl Psychol       Date:  2001-06

2.  Justice at work, job stress, and employee health.

Authors:  Kaori Fujishiro; Catherine A Heaney
Journal:  Health Educ Behav       Date:  2007-11-15

3.  Perceived unfairness and employee health: a meta-analytic integration.

Authors:  Jordan M Robbins; Michael T Ford; Lois E Tetrick
Journal:  J Appl Psychol       Date:  2011-09-19

4.  Effects of organizational justice on depressive symptoms and sickness absence: a longitudinal perspective.

Authors:  Jan F Ybema; Kees van den Bos
Journal:  Soc Sci Med       Date:  2010-02-12       Impact factor: 4.634

5.  Psychosocial work characteristics and incidence of newly diagnosed depression: a prospective cohort study of three different models.

Authors:  Jaana Ylipaavalniemi; Mika Kivimäki; Marko Elovainio; Marianna Virtanen; Liisa Keltikangas-Järvinen; Jussi Vahtera
Journal:  Soc Sci Med       Date:  2005-01-11       Impact factor: 4.634

6.  Organisational injustice and impaired cardiovascular regulation among female employees.

Authors:  M Elovainio; M Kivimäki; S Puttonen; H Lindholm; T Pohjonen; T Sinervo
Journal:  Occup Environ Med       Date:  2006-02       Impact factor: 4.402

7.  Injustice at work and incidence of psychiatric morbidity: the Whitehall II study.

Authors:  J E Ferrie; J Head; M J Shipley; J Vahtera; M G Marmot; M Kivimäki
Journal:  Occup Environ Med       Date:  2006-05-12       Impact factor: 4.402

8.  Organisational justice and health of employees: prospective cohort study.

Authors:  M Kivimäki; M Elovainio; J Vahtera; J E Ferrie
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

9.  Justice at work and metabolic syndrome: the Whitehall II study.

Authors:  David Gimeno; Adám G Tabák; Jane E Ferrie; Martin J Shipley; Roberto De Vogli; Marko Elovainio; Jussi Vahtera; Michael G Marmot; Mika Kivimäki
Journal:  Occup Environ Med       Date:  2009-10-09       Impact factor: 4.402

10.  Unfairness and health: evidence from the Whitehall II Study.

Authors:  Roberto De Vogli; Jane E Ferrie; Tarani Chandola; Mika Kivimäki; Michael G Marmot
Journal:  J Epidemiol Community Health       Date:  2007-06       Impact factor: 3.710

View more
  5 in total

1.  Associations between organizational injustice and work ability, self-reported disability days, and medical consultations: cross-sectional findings from employees with prior sickness absence payments.

Authors:  Katja Spanier; Elke Peters; Elliot Michel; Friedrich Michael Radoschewski; Matthias Bethge
Journal:  Int Arch Occup Environ Health       Date:  2017-06-28       Impact factor: 3.015

2.  Injustice at work affects work ability and role functioning: findings of a cohort study.

Authors:  Katja Spanier; Elliot Michel; Elke Peters; Friedrich Michael Radoschewski; Matthias Bethge
Journal:  Int J Public Health       Date:  2017-11-14       Impact factor: 3.380

3.  Organizational justice, psychological distress, and stress-related behaviors by occupational class in female Japanese employees.

Authors:  Yumiko Kobayashi; Naoki Kondo
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

4.  Trust in the Work Environment and Cardiovascular Disease Risk: Findings from the Gallup-Sharecare Well-Being Index.

Authors:  Toni Alterman; Rebecca Tsai; Jun Ju; Kevin M Kelly
Journal:  Int J Environ Res Public Health       Date:  2019-01-15       Impact factor: 3.390

5.  Organizational justice and illness reporting among Japanese employees with chronic diseases.

Authors:  Hisashi Eguchi; Akizumi Tsutsumi; Akiomi Inoue; Yuko Kachi
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.